Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.iovance.com
Iovance Biotherapeutics, Inc. News Releases
Get the latest updates from Iovance Biotherapeutics, Inc. News Releases directly as they happen.
Follow now 57 followers
Latest posts
Last updated 1 day ago
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
1 day ago
1Q25 Total Product Revenue of $49.3M FY25 Total Product Revenue Guidance Revised...
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
8 days ago
SAN CARLOS, Calif. , May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
17 days ago
SAN CARLOS, Calif. , April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
22 days ago
SAN CARLOS, Calif. , April 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
about 2 months ago
SAN CARLOS, Calif. , March 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
2 months ago
Significant Demand for Amtagvi® (Lifileucel) Continues with Total Product Revenue of $73.7M...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3 months ago
SAN CARLOS, Calif. , Feb. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
3 months ago
SAN CARLOS, Calif. , Feb. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3 months ago
SAN CARLOS, Calif. , Feb. 12, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
3 months ago
SAN CARLOS, Calif. , Feb. 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
4 months ago
SAN CARLOS, Calif. , Jan. 17, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
5 months ago
SAN CARLOS, Calif. , Dec. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics...